Further questions.
1. Nasopharynx is not treated electively.
No. The only occasion where I might think about doing this is when there is a Level 5 LN. In the case where I believed that NP was the culprit, I would use bilateral neck RT with nasopharynx BUT I would curtails doses to oral/pharyngeal mucosa and parotid, i.e., accept less PTV coverage in node negative areas to keep parotid doses low (mean parotid doses ~16-18Gy)
2. Contralateral neck, do i treat as microscopic to 50 Gy.
This is a judgment call. I treat ipsilateral neck alone. If you treat contralateral neck, even with IMRT, you will be hard pressed to deliver high doses if you see a primary appear later. As I see it, the choice is everything (nasopharynx, tonsil, hypopharynx and bilateral necks) or what is at high risk (ipsilateral neck alone)
3. I have no clue regarding ( this corresponds to the minimal penumbra id conformality is 100% )
- What I mean is this - when you define a high dose PTV, you are actually defining the 100% conformality line. That is, the PERFECT plan would have the 95% isodose lying directly over the PTV line.
- When you have defined this PTV=95% isodose line concept, the physics reality is that the PERFECT penumbra around that line will be about 5mm to 50% (corresponds to the old light field edge), and by 7mm the dose will be down to ~25-30%. You can't change this, it's a matter of physics. You can visualize this by expanding the PTV by 7mm (the name I give it is PTV_PRV) - its a theoretical volume and only used to build PRVs.
- Is this second assertion clear?
- So now you have the OAR - it moves by the same amount as the CTV movement (in my case 3mm). That expanded (OAR + movement) becomes a slightly larger volume and has three parts:
- the part that overlaps the PTV - you can't alter the dose here because in assigning a high dose PTV, you have decided to deliver target dose there and sacrifice the organ.
- the part that overlaps the penumbral margin (that is, the part of the expanded OAR inside the PTV_PRV) - you can't alter the dose here either because having decided on a high dose region, you HAVE TO HAVE A PENUMBRA AROUND IT.
- the part that is outside 1 and 2, to which you have some chance of altering dose, called "Organ_PRV".
- The IMRT constraint is then set to this Organ_PRV volume and the dose constraint is set ridiculous low ("unattainable" is a good place to start!) and then gradually increased until an acceptable plan is obtained. There are two things to say about this [(OAR + 3mm - PTV_PRV) = Organ_PRV] approach:
-
- this approach allows the algorithm to concentrate on what is important, that is, spare dose to areas where dose can be spared.
- this approach uses an ALARA approach to dose restriction to critical structures. Restriction the parotid mean dose to 26Gy is not an acceptable aim. If the ALARA dose is a mean of 16Gy, then why deliver 26Gy? If the ALARA dose is 32Gy when ensuring PTV coverage, then why deliver 26Gy and underdose the PTV?